TP53 and fibrosarcoma: We tested the effect of increasing IR doses on four cancer cell lines from different origins: CT26 colon carcinoma, MCA205 fibrosarcoma, 71-7 KrasG12D;p53−/− lung adenocarcinoma, and the Murine Uterine Cervix Cancer (MUCC) cells.